- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cabaletta Bio Inc (CABA)
Assess today's live Cabaletta Bio Inc (CABA) share price, performance and insights using our live NASDAQ: CABA stock exchange data.
Analyse the historical data and Cabaletta Bio Inc share price performance charts on this page. Our technical summary section provides analysis on Cabaletta Bio share price buy/sell indicators using real-time data (or discuss the Cabaletta Bio (CABA) stock price today with other investors in the Cabaletta Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CABA share price (ISIN: US12674W1099) to enhance your trading decisions with our free investment tools and resources.
What Is the Cabaletta Bio Inc Share Price Today?
The Cabaletta Bio share price today is 2.800.
What Is the Stock Symbol for Cabaletta Bio Inc
The stock symbol (or 'ticker') for Cabaletta Bio Inc is "CABA."
What Stock Exchange Does Cabaletta Bio Inc Trade On?
Cabaletta Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Cabaletta Bio Inc a Good Stock to Buy?
Determining whether Cabaletta Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Cabaletta Bio Inc share price performance charts on this page. Our technical summary section provides analysis on Cabaletta Bio share price buy/sell indicators using real-time data (or discuss the Cabaletta Bio (CABA) stock price today with other investors in the Cabaletta Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CABA share price (ISIN: US12674W1099) to enhance your trading decisions with our free investment tools and resources.
What Is the Cabaletta Bio Inc Share Price Today?
The Cabaletta Bio share price today is 2.800.
What Is the Stock Symbol for Cabaletta Bio Inc
The stock symbol (or 'ticker') for Cabaletta Bio Inc is "CABA."
What Stock Exchange Does Cabaletta Bio Inc Trade On?
Cabaletta Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Cabaletta Bio Inc a Good Stock to Buy?
Determining whether Cabaletta Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.745
2.940
52 wk Range
0.986
3.670
CABA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.7452.940
52 wk Range
0.9863.670
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CABA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
13.125
Upside
+368.75%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Cabaletta Bio Company Profile
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, non-renal systemic lupus erythematosus, relapsing and progressive multiple sclerosis, mucocutaneous and mucosal pemphigus vulgaris (PV), systemic sclerosis, and generalized myasthenia gravis. The company also develops DSG3-CAART, a CAAR T cell therapy that is in Phase 1 clinical trial for the treatment of mucosal PV; and MuSK-CAART, an investigational cell therapy in Phase 1 trial for treating patients with anti-muscle-specific kinase (MuSK) antibody positive myasthenia gravis. It has collaborations with the University of Pennsylvania and the Children’s Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; Autolus Holdings (UK) Limited; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Cabaletta Bio Inc SWOT Analysis
CAR-T Trailblaze | Cabaletta Bio leads in developing CAR-T therapies for autoimmune diseases, targeting conditions like lupus and myositis with promising clinical results |
Market Disconnect | Explore the intriguing gap between positive clinical reception and market skepticism, presenting a unique investment opportunity in the biotech secto |
Strategic Positioning | Delve into Cabaletta's first-mover advantage in CD19 auto-CAR-T therapy and its potential to reshape treatment paradigms for autoimmune disorders |
Future Prospects | Analyst targets range from $6 to $35, reflecting diverse views on Cabaletta's potential to capitalize on its innovative therapies and market position |
Compare CABA to Peers and Sector
Metrics to compare | CABA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCABAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.7x | −2.6x | −0.5x | |
PEG Ratio | 0.15 | −0.02 | 0.00 | |
Price/Book | 1.9x | 1.6x | 2.6x | |
Price / LTM Sales | - | 7.3x | 3.3x | |
Upside (Analyst Target) | - | 190.4% | 47.0% | |
Fair Value Upside | Unlock | 22.1% | 5.7% | Unlock |
Analyst Ratings
8 Buy
2 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.125
(+368.75% Upside)
Earnings
Latest Release
Nov 10, 2025
EPS / Forecast
-0.44 / -0.4721
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Cabaletta Bio (CABA) Share Price Today?
The live Cabaletta Bio share price today is 2.800
What Stock Exchange Does Cabaletta Bio (CABA) Trade On?
Cabaletta Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Cabaletta Bio?
The stock symbol (also called a 'ticker') for Cabaletta Bio is "CABA."
What Is the Current Cabaletta Bio Market Cap?
As of today, Cabaletta Bio market capitalisation is 269.540M.
What Is Cabaletta Bio's (CABA) Earnings Per Share (TTM)?
The Cabaletta Bio EPS is currently -2.408 (Trailing Twelve Months).
When Is the Next Cabaletta Bio Earnings Date?
Cabaletta Bio's next earnings report will be released on 12/03/2026.
Is CABA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Cabaletta Bio moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Cabaletta Bio Stock Split?
Cabaletta Bio has split 0 times. (See the CABA stock split history page for full effective split date and price information.)
How Many Employees Does Cabaletta Bio Have?
Cabaletta Bio has 150 employees.
What is the current trading status of Cabaletta Bio (CABA)?
As of 17/02/2026, Cabaletta Bio (CABA) is trading at a price of 2.800, with a previous close of 2.800. The stock has fluctuated within a day range of 2.745 to 2.940, while its 52-week range spans from 0.986 to 3.670.
What Is Cabaletta Bio (CABA) Price Target According to Analysts?
The average 12-month price target for Cabaletta Bio is USD13.125, with a high estimate of USD30 and a low estimate of USD2. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +368.75% Upside potential.
What Is the CABA Premarket Price?
CABA's last pre-market stock price is 2.850. The pre-market share volume is 44,850.000, and the stock has decreased by 0.050, or 1.790%.
What Is the CABA After Hours Price?
CABA's last after hours stock price is 2.850, the stock has decreased by 0.050, or 1.790%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.